Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR201 OIT for Hen Egg Allergy
NCT04056299Phase 2Terminated
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of AR201 in egg allergy. Started Aug 2019; status: terminated.
02
Drugs
AR201
03
Conditions
egg allergy
Beyond the preview
Go deeper on NCT04056299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056299.